A new broad-spectrum coronavirus antiviral, ASAP-0017445, has been nominated as a pre-clinical drug candidate by the Drugs for Neglected Diseases initiative (DNDi). The candidate is the first ...

A research team has successfully developed a self-locked Raman-electro-optic (REO) microcomb on a single lithium niobate chip. By synergistically harnessing the electro-optic (EO), Kerr, and Raman ...

There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...

Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases. Their study, ...

We're close to the world's first-ever broad-spectrum antiviral, which could be deployed against future pandemic threats. In a breakthrough, researchers at the City University of New York have ...

A sugar present on virus envelopes might become the target of new antiviral treatments for a range of viruses, researchers report August 27 in Science Advances. This treatment, shown to shut down ...

Synthetic carbohydrate receptors act as broad-spectrum antivirals by binding to conserved N-glycans and in doing so, blocking virus binding and virus fusion. Unlike bacterial infections, which doctors ...

Deficiencies in interferon-stimulated gene 15 (ISG15), a protein that normally regulates the immune response, causes mild but persistent inflammation. However, its absence also provides an unexpected ...

In addition to offering moisturizing and UV defense, it helps protect against environmental stressors. Lastly, Prism Protection aims to brighten and balance the skin, reduce hyperpigmentation, soothe ...

SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...